Supporting the role of 5HT neurotransmission in cataplexy, Hasegawa and colleagues showed that HCRT neuron-dependent activation of 5HT release in the amygdala is required to suppress cataplexy40. The gene discussed is HCRT; the disease is Cataplexy.